Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using ...

Research suggests that it is important for clinicians to identify the risk for ILD in patients with SSc so that therapy can be initiated.

New-onset interstitial lung disease can be detected up to 10 years after initial negative screening in patients with systemic sclerosis, with a higher mortality risk vs those without lung involvement.

Researchers at the University of Exeter and clinical radiopharmaceutical company Serac Healthcare Ltd are researching a new molecular imaging marker which could help to detect disease progression ...

UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease (ILD), an increasingly common condition that is a leading reason for lung ...

PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging, with variable criteria across studies. Risk factors for PPF include older age, male sex, smoking, ...

A new study conducted by researchers at Queen Elizabeth Hospital Birmingham in Birmingham, Great Britain, evaluated outcomes and toxicity associated with stereotactic radiotherapy in patients with ...